Skip to main content
. 2026 Sep 25;18(19):3119. doi: 10.3390/cancers18193119
Abbreviation Definition
ADC antibody–drug conjugate
ADT androgen-deprivation therapy
ARPI androgen receptor pathway inhibitor
ctDNA circulating tumour DNA
dMMR mismatch repair deficient
FDG fluorodeoxyglucose
HRR homologous recombination repair
IPCW inverse probability of censoring weighting
ITT intention to treat
mCRPC metastatic castration-resistant prostate cancer
mHSPC metastatic hormone-sensitive prostate cancer
MSI-H microsatellite instability high
NEPC neuroendocrine prostate cancer
NSE neuron-specific enolase
ORR objective response rate
OS overall survival
PARPi poly(ADP-ribose) polymerase inhibitor
PSA prostate-specific antigen
PSMA prostate-specific membrane antigen
RLT radioligand therapy
rPFS radiographic progression-free survival
SUV standardised uptake value